Why are angiotensin concentrations so high in the kidney?

Current Opinion in Nephrology and Hypertension

Volumn 13, Issue 1, 2004, Pages 107-115

  Navar, L Gabriel ^a   Nishiyama, Akira ^b  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

Intrarenal angiotensin II; Intrarenal angiotensinogen; Renal AT1 receptors; Renal interstitial fluid; Tubular angiotensin II

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN I; ANGIOTENSINOGEN; MESSENGER RNA;

ANGIOTENSIN BLOOD LEVEL; CELLULAR DISTRIBUTION; ENDOCYTOSIS; HOMEOSTASIS AND REGULATION; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; HYPERTENSION; INTERSTITIAL FLUID; KIDNEY BLOOD FLOW; KIDNEY INJURY; KIDNEY INTERSTITIUM; KIDNEY TUBULE ABSORPTION; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; REVIEW; SODIUM BALANCE; SODIUM RETENTION; TISSUE LEVEL; URINARY EXCRETION; WATER RETENTION;

ANGIOTENSIN II; ANGIOTENSINS; ANIMALS; EXTRACELLULAR FLUID; HUMANS; KIDNEY; KIDNEY TUBULES; TISSUE DISTRIBUTION;

EID: 4043157826     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200401000-00015     Document Type: Review

References (85)

1. Navar LG, Inscho EW, Majid SA, et al. Paracrine regulation of the renal microcirculation [Review; 1214 refs]. Physiol Rev 1996; 76:425-536.
2. Re RN. The intracrine hypothesis and intracellular peptide hormone action. Bioessays 2003; 25:401-409. An interesting commentary on the role of intraceullular peptides to activate intracellular signaling mechanisms. The intracellular RAS is reviewed to illustrate intracrine mechanisms.
3. Navar LG, Harrison-Bernard LM, Wang C-T, et al. Concentrations and actions of intraluminal angiotensin II. J Am Soc Nephrol 1999; 10:S189-S195.
4. Navar LG, Harrison-Bernard LM, Nishiyama A, Kobori H. Regulation of intrarenal angiotensin II in hypertension. Hypertension 2002; 39:316-322. This review covers the older data relating to changes in intrarenal angiotensin II in angiotensin II-dependent hypertension.
5. Nishiyama A, Seth DM, Navar LG. Renal interstitial fluid angiotensin I and angiotensin II concentrations during local angiotensin-converting enzyme inhibition. J Am Soc Nephrol 2002; 13:2207-2212.
6. Nishiyama A, Seth DM, Navar LG. Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats. Hypertension 2002; 39:129-134.
7. 1 receptors.
8. 1 receptor-mediated uptake.
9. van Kats JP, Schalekamp MA, Verdouw PD, et al. Intrarenal angiotensin II: interstitial and cellular levels and site of production. Kidney Int 2001; 60:2311-2317.
10. Fox J, Guan S, Hymel AA, Navar LG. Dietary Na and ACE inhibition effects on renal tissue angiotensin I and II and ACE activity in rats. Am J Physiol - Renal Physiol 1992; 262:F902-F909.
11. Campbell DJ. Differential regulation of angiotensin peptides in plasma and kidney: effects of adrenalectomy and estrogen treatment. Clin Exp Hypertens 1997; 19:687-698.
12. Braam B, Mitchell KD, Fox J, Navar LG. Proximal tubular secretion of angiotensin II in rats. Am J Physiol - Renal Physiol 1993; 264:F891-F898.
13. Siragy HM, Howell NL, Ragsdale NV, Carey RM. Renal interstitial fluid angiotensin: modulation by anesthesia, epinephrine, sodium depletion and renin inhibition. Hypertension 1995; 25:1021-1024.
14. Campbell DJ, Lawrence AC, Towrie A, et al. Differential regulation of angiotensin peptide levels in plasma and kidney of the rat. Hypertension 1991; 18:763-773.
15. 1A receptors. Am J Physiol - Renal Physiol 1999; 277:F303-F311.
16. Ingert C, Grima M, Coquard C, et al. Effects of dietary salt changes on renal renin-angiotensin system in rats. Am J Physiol Renal Physiol 2002; 283:F995-F1002.
17. Reams G, Villarreal D, Wu Z, Bauer JH. Renal tissue angiotensin II: response to infusions of angiotensin I and an angiotensin-converting enzyme inhibitor. Am J Kidney Dis 1993; 22:851-857.
18. Komine N, Khang S, Wead LM, et al. Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels. Am J Kidney Dis 2002; 39:159-164. This study demonstrates that the combined treatment of rats maintained on a low-salt diet with captopril and losartan reduced intrarenal angiotensin II levels to a greater extent than treatment with either agent alone. The synergistic actions of these two agents may have important implications for long-term organ protection in hypertension and renal disease.
19. Yamada K, Iyer SN, Chappell MC, et al. Differential response of angiotensin peptides in the urine of hypertensive animals. Regul Pept 1999; 80:57-66.
20. Zou L, Imig JD, Von Thun AM, et al. Receptor-mediated intrarenal ANG II augmentation in ANG II-infused rats. Hypertension 1996; 28:669-677.
21. Tokuyama H, Hayashi K, Matsuda H, et al. Differential regulation of elevated renal angiotensin II in chronic renal ischemia. Hypertension 2002; 40:34-40. This paper provides further data supporting enhanced intrarenal angiotensin II in non-clipped as well as in clipped kidneys. The elevated angiotensin II in clipped kidneys was suppressed by a chymase inhibitor but not by an ACE inhibitor, whereas an ACE inhibitor, but not a chymase inhibitor, inhibited the intrarenal angiotensin II levels in the non-clipped kidneys. The data indicate that chymase activity is enhanced in clipped kidneys, whereas ACE-mediated angiotensin II generation is primarily responsible for elevated angiotensin II contents in nonclipped kidneys.
22. Meng QC, Durand J, Chen Y-F, Oparil S. Effects of dietary salt on angiotensin peptides in kidney. J Am Soc Nephrol 1995; 6:1209-1215.
23. 1 receptor expression in proximal tubules and adrenal glands was maintained.
24. 1 receptor blockade in nonclipped kidneys of Goldblatt hypertensive rats. Hypertension 1999; 33:102-107.
25. 1 receptor. Am J Hypertens 1998; 11:570-578.
26. 1A) receptor endocytosis. Clin Exp Pharmacol Physiol 1996; 23:S74-S80.
27. Navar LG, Mitchell KD, Harrison-Bernard LM, et al. Intrarenal angiotensin II levels in normal and hypertensive states. Journal Renin Angiotensin Aldosterone System 2001; 2:S176-S184.
28. 1 receptors in renal cells. Neither nuclear nor plasma membrane angiotensin II receptors were diminished in angiotensin II-infused hypertension.
29. Harrison-Bernard LM, El-Dahr SS, O'Leary DF, Navar LG. Regulation of angiotensin II type 1 receptor mRNA and protein in angiotensin II-induced hypertension. Hypertension 1999; 33:340-346.
30. 1 receptor binding was unchanged but ACE binding was increased.
31. Wang C-T, Chin SY, Navar LG. Impairment of pressure-natriuresis and renal autoregulation in ANG II-infused hypertensive rats. Am J Physiol - Renal Physiol 2000; 279:F319-F325.
32. Edgley AJ, Kett MM, Anderson WP. Evidence for renal vascular remodeling in angiotensin II-induced hypertension. J Hypertens 2003; 21:1401-1406.
33. Mackie FE, Meyer TW, Campbell DJ. Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency. Kidney Int 2002; 61:555-563. Tissue angiotensin II levels were found to be elevated in the peri-infarct portion of the kidneys in rats subjected to 5/6th renal mass removal. These were reduced by enalapril but increased further with nifedipine.
34. Maric C, Casley D, Harris PJ, Alcorn D. Angiotensin II binding to renomedullary interstitial cells is regulated by osmolality. J Am Soc Nephrol 2001; 12:450-455.
35. Zhuo J, Dean R, Maric C, et al. Localization and interactions of vasoactive peptide receptors in renomedullary interstitial cells of the kidney [Review; 29 refs]. Kidney Int 1998; 67 (Suppl.):S22-S28.
36. 1 receptor blockers. In: Epstein M, Brunner HR, editors. Angiotensin II receptor antagonists. Philadelphia: Hanley and Belfus, Inc., 2000. pp. 189-214.
37. 2-mediated activation of adenylyl cyclase.
38. 2 receptor in a renal wrap hypertension model. Hypertension 1999; 33:1237-1242.
39. 1 receptor-mediated process, and can be dissociated from the changes in plasma angiotensin II concentrations, thus supporting the independent regulation of RIF angiotensin II concentrations.
40. Wang C-T, Navar LG, Mitchell KD. Proximal tubular fluid angiotensin II levels in angiotensin II-induced hypertensive rats. J Hypertens 2003; 21:353-360. This paper shows that proximal tubular fluid concentrations of angiotensin II remain elevated in angiotensin II-infused rats and are not suppressed by the elevated arterial pressure. The inappropriate maintenance of nanomolar concentrations of angiotensin II in proximal tubular fluid may contribute to the augmented sodium reabsorption and impaired pressure natriuresis, leading to hypertension.
41. 2) receptors modulate renal cellular uptake of angiotensin II [Abstract]. J Hypertens 2000; 18:392.
42. Kobori H, Harrison-Bernard LM, Navar LG. Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension. J Am Soc Nephrol 2001; 12:431-439.
43. Seikaly MG, Arant BS Jr, Seney FD Jr. Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J Clin Invest 1990; 86:1352-1357.
44. Navar LG, Lewis L, Hymel A, et al. Tubular fluid concentrations and kidney contents of angiotensins I and II in anesthetized rats. J Am Soc Nephrol 1994; 5:1153-1158.
45. Boer WH, Braam B, Fransen R, et al. Effects of reduced renal perfusion pressure and acute volume expansion on proximal tubule and whole kidney angiotensin II content in the rat. Kidney Int 1997; 51:44-49.
46. Baum M, Quigley R, Quan A. Effect of luminal angiotensin II on rabbit proximal convoluted tubule bicarbonate absorption. Am J Physiol - Renal Physiol 1997; 273:F595-F600.
47. Quan A, Baum M. Endogenous production of angiotensin II modulates rat proximal tubule transport. J Clin Invest 1996; 97:2878-2882.
48. 1 receptor. Br J Pharmacol 1996; 119:617-618.
49. Harris PJ, Navar LG. Tubular transport responses to angiotensin. Am J Physiol - Renal Physiol 1985; 248:F621-F630.
50. Mitchell KD, Navar LG. Intrarenal actions of angiotensin II in the pathogenesis of experimental hypertension. In: Laragh JH, Brenner BM, editors. Hypertension: pathophysiology, diagnosis, and management. New York: Raven Press Ltd.; 1995. pp. 1437-1450.
51. Mitchell KD, Jacinto SM, Mullins JJ. Proximal tubular fluid, kidney, and plasma levels of angiotensin II in hypertensive ren-2 transgenic rats. Am J Physiol - Renal Physiol 1997; 273:F246-F253.
52. Kwon TH, Nielsen J, Kim YH, et al. Regulation of sodium transporters in the thick ascending limb of rat kidney: response to angiotensin II. Am J Physiol Renal Physiol 2003; 285:F152-F165. Chronic treatment with angiotensin II upregulated the expression of proximal tubule sodium/hydrogen exchanger.
53. Nguyen G, Delarue F, Burckle C, et al. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 2002; 109:1417-1427. The expression cloning of the human renin receptor binding of renin increased the catalytic efficiency of angiotensin I formation and induced intracellular signaling associated with the activation of MAPKs.
54. Ingelfinger JR, Jung F, Diamant D, et al. Rat proximal tubule cell line transformed with origin-defective SV40 DNA: autocrine ANG II feedback. Am J Physiol - Renal Physiol 1999; 276:F218-F227.
55. Hunt MK, Ramos SP, Geary KM, et al. Colocalization and release of angiotensin and renin in renal cortical cells. Am J Physiol - Renal Physiol 1992; 263:F363-F373.
56. Darby IA, Sernia C. In situ hybridization and immunohistochemistry of renal angiotensinogen in neonatal and adult rat kidneys. Cell Tiss Res 1995; 281:197-206.
57. Ding Y, Davisson RL, Hardy DO, et al. The kidney androgen-regulated protein promoter confers renal proximal tubule cell-specific and highly androgen-responsive expression on the human angiotensinogen gene in transgenic mice. J Biol Chem 1997; 272:28142-28148.
58. Rohrwasser A, Morgan T, Dillon HF, et al. Elements of a paracrine tubular renin-angiotensin system along the entire nephron. Hypertension 1999; 34:1265-1274.
59. Navar LG, Imig JD, Zou L, Wang C-T. Intrarenal production of angiotensin II. Semin Nephrol 1997; 17:412-422.
60. Jeunemaitre X, Ménard J, Clauser E, Corvol P. Angiotensinogen: molecular biology and genetics. In: Laragh JH, Brenner BM, editors. Hypertension: pathophysiology, diagnosis, and management. New York: Raven Press Ltd.; 2000. pp. 1653-1665.
61. Lalouel J-M, Rohrwasser A, Terreros D, et al. Angiotensinogen in essential hypertension: from genetics to nephrology. J Am Soc Nephrol 2001; 12:606-615.
62. Kobori H, Harrison-Bernard LM, Navar LG. Enhancement of angiotensinogen expression in angiotensin II-dependent hypertension. Hypertension 2001; 37:1329-1335.
63. Hsieh TJ, Zhang SL, Filep JG, et al. High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells. Endocrinology 2002; 143:2975-2985. This paper shows that angiotensinogen mRNA expression in rat proximal tubular cells is increased by high glucose, but this effect is prevented by the administration of an antioxidant and a p38 MAPK inhibitor. The data indicate that the stimulatory action of high glucose on angiotensinogen gene expression in the proximal tubular cells is mediated via reactive oxygen species generation and subsequent p38 MAPK activation.
64. 2 receptor expression might contribute to early diabetic nephropathy.
65. Zimpelmann J, Kumar D, Levine DZ, et al. Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat. Kidney Int 2000; 58:2320-2330.
66. 1 receptor protein expression during the early stage of diabetes mellitus. Int J Exp Diabetes Res 2002; 3:97-108.
67. Kobori H, Harrison-Bernard LM, Navar LG. Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production. Kidney Int 2002; 61:579-585.
68. Kobori H, Nishiyama A, Harrison-Bernard LM, Navar LG. Urinary angiotensinogen as an indicator of intrarenal angiotensin status in hypertension. Hypertension 2003; 41:42-49. This paper shows that intrarenal angiotensinogen expression and the urinary excretion of angiotensinogen are significantly increased in angiotensin II-dependent, but not in angiotensin II-independent hypertensive rats, indicating a positive feedback system that leads to the further intrarenal production of angiotensin II during the development of angiotensin II-dependent hypertension.
69. Kobori H, Nishiyama A, Abe Y, Navar LG. Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Hypertension 2003; 41:592-597. This study reports an enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats that is not associated with an increase in the circulating RAS.
70. Moosavi SM, Johns EJ. The effect of isoprenaline infusion on renal renin and angiotensinogen gene expression in the anaesthetised rat. Exp Physiol 2003; 88:221-227. The administration of a β-adrenoceptor agonist stimulated both renin and renal angiotensinogen expression, providing evidence that catecholamines are involved in the mechanism that alters the expression of renal RAS genes.
71. Moe OW, Ujiie K, Star RA, et al. Renin expression in renal proximal tubule. J Clin Invest 1993; 91:774-779.
72. Henrich WL, McAllister EA, Eskue A, et al. Renin regulation in cultured proximal tubular cells. Hypertension 1996; 27:1337-1340.
73. Sibony M, Gasc J-M, Soubrier F, et al. Gene expression and tissue localization of the two isoforms of angiotensin I converting enzyme. Hypertension 1993; 21:827-535.
74. Casarini DE, Boim MA, Stella RCR, et al. Angiotensin I-converting enzyme activity in tubular fluid along the rat nephron. Am J Physiol - Renal Physiol 1997; 272:F405-F409.
75. Wang T, Giebisch G. Effects of angiotensin II on electrolyte transport in the early and late distal tubule in rat kidney. Am J Physiol - Renal Physiol 1996; 271:F143-F149.
76. Terada Y, Tomita K, Nonoguchi H, Marumo F. PCR localization of angiotensin II receptor and angiotensinogen mRNAs in rat kidney. Kidney Int 1993; 43:1251-1259.
77. Levine DZ, Iacovitti M, Buckman S, Burns KD. Role of angiotensin II in dietary modulation of rat late distal tubule bicarbonate flux in vivo. J Clin Invest 1996; 97:120-125.
78. - reabsorption. Am J Physiol - Renal Physiol 1996; 271:F977-F984.
79. 1 receptor in adult rat kidney using a monoclonal antibody. Am J Physiol - Renal Physiol 1997; 273:F170-F177.
80. Reams G, Villarreal D, Wu Z, Bauer JH. Urinary angiotensin II: a marker of renal tissue activity? Nephron 1994; 67:450-458.
81. Peti-Peterdi J, Warnock DG, Bell PD. Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT(1) receptors. J Am Soc Nephrol 2002; 13:1131-1135. Using isolated perfused cortical collecting duct segments, angiotensin II added to the lumen increased intracellular sodium uptake and this effect was prevented after the blockade of the amiloride-sensitlve sodium channel. The results indicate that distal nephron angiotensin II may regulate amiloride-sensitive sodium channel activity.
82. Davisson RL, Ding Y, Stec DE, et al. Novel mechanism of hypertension revealed by cell-specific targeting of human angiotensinogen in transgenic mice. Physiol Genomics 1999; 1:3-9.
83. Komlosi P, Fuson AL, Fintha A, et al. Angiotensin I conversion to angiotensin II stimulates cortical collecting duct sodium transport. Hypertension 2003; 42:195-199. This study reports that angiotensin I added to the perfusate of cortical collecting ducts leads to angiotensin II stimulation of amiloride-sensitive sodium channel activity and that ACE was present in the cortical collecting duct, supporting the hypothesis that angiotensin I to angiotensin II conversion can occur in the cortical collecting duct.
84. Navar LG, Hamm LL. The kidney in blood pressure regulation. In: Wilcox CS, editor. Atlas of diseases of the kidney. Hypertension and the kidney. Philadelphia: Current Medicine, Inc.; 1999. pp. 1.1-1.22.
85. Wolf G. The renin-angiotensin system and progression of renal diseases. Hamburg: Karger; 2002. pp. 1-268.